Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer

Jaguar HealthDec 13 00:00 ET

Jaguar Health's Napo Pharmaceuticals Reports Crofelemer Shows Statistically Significant Results In Phase 3 OnTarget Trial For Breast Cancer Patients

BenzingaDec 12 09:23 ET

Poster Presentation Describing the Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients to Take Place December 11, 2024 at San Antonio Breast Cancer Symposium (SABCS)

Jaguar HealthDec 9 00:00 ET

U.S. Investigator-Initiated Trial To Evaluate Efficacy And Safety Of Jaguar Health's Crofelemer For Short Bowel Syndrome With Intestinal Failure Begins

BenzingaDec 6 08:34 ET

U.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health's Crofelemer for Short Bowel Syndrome With Intestinal Failure (SBS-IF) Begins

Jaguar HealthDec 6 00:00 ET

Jaguar Health Announces Publication of Article on Canalevia-CA1

TipRanksDec 5 12:15 ET